James E Galvin

No ORCID on file · 1 paper in corpus · active 2021

Study types

  • other 1

Condition tags

  • endometriosis 1
other 2021
Rationale, study design and implementation of the LUCINDA Trial: Leuprolide plus Cholinesterase Inhibition to reduce Neurologic Decline in Alzheimer's
Contemporary clinical trials ·doi:10.1016/j.cct.2021.106488

The LUCINDA Trial (Leuprolide plus Cholinesterase Inhibition to reduce Neurologic Decline in Alzheimer's) is a 52 week, randomized, placebo-controlled trial of leuprolide acetate (Eligard) in women with Alzheimer's disease (AD). Leuprolide …